{"id":17322,"date":"2026-05-06T11:25:39","date_gmt":"2026-05-06T14:25:39","guid":{"rendered":"https:\/\/www.biolabeco.com.br\/?post_type=imprensa&#038;p=17322"},"modified":"2026-06-02T11:38:35","modified_gmt":"2026-06-02T14:38:35","slug":"biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca","status":"publish","type":"imprensa","link":"https:\/\/www.biolabeco.com.br\/zh\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/","title":{"rendered":"Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca"},"content":{"rendered":"\n<p><em>L\u00edder em cardiologia, farmac\u00eautica passa a oferecer medicamento para condi\u00e7\u00e3o que afeta 2 milh\u00f5es de brasileiros<\/em><\/p>\n\n\n\n<p>A Biolab Farmac\u00eautica, uma das dez maiores ind\u00fastrias do setor no pa\u00eds e l\u00edder em medicamentos para a sa\u00fade cardiovascular, amplia a sua atua\u00e7\u00e3o em cardiologia com a combina\u00e7\u00e3o molecular de sacubitril\/valsartana. O medicamento chega em seu portf\u00f3lio de comercializa\u00e7\u00e3o como uma op\u00e7\u00e3o de tratamento para aproximadamente 2 milh\u00f5es de brasileiros que convivem com a insufici\u00eancia card\u00edaca (IC), segundo dados do Minist\u00e9rio da Sa\u00fade.<a href=\"#_edn1\" id=\"_ednref1\">[i]<\/a><\/p>\n\n\n\n<p>O cen\u00e1rio da insufici\u00eancia card\u00edaca (IC) no Brasil \u00e9 cr\u00edtico, com o registro de cerca de 240 mil novos casos anualmente. A condi\u00e7\u00e3o, caracterizada pela incapacidade do m\u00fasculo card\u00edaco de bombear o sangue com a for\u00e7a necess\u00e1ria, imp\u00f5e limites f\u00edsicos severos aos pacientes, como falta de ar, incha\u00e7o e fadiga extrema. Entre 2011 e 2021, o SUS registrou mais de 2,5 milh\u00f5es de interna\u00e7\u00f5es pela doen\u00e7a<a href=\"#_edn2\" id=\"_ednref2\">[ii]<\/a>, mas o desafio persiste mesmo ap\u00f3s a sa\u00edda do hospital: o progn\u00f3stico p\u00f3s-alta permanece preocupante, com 50% dos pacientes a serem readmitidos em 90 dias ap\u00f3s a alta. <a href=\"#_edn3\" id=\"_ednref3\">[iii]<\/a><\/p>\n\n\n\n<p>Neste contexto, o novo tratamento oferecido pela Biolab Farmac\u00eautica, da classe dos INRAs &#8211; Inibidor da Neprilisina e do Receptor de Angiotensina, foca em reduzir a mortalidade e os internamentos. <a href=\"#_edn4\" id=\"_ednref4\">[iv]<\/a>A terapia atua de forma dupla ao relaxar os vasos sangu\u00edneos e eliminar o excesso de l\u00edquidos, reduzindo a carga de trabalho do cora\u00e7\u00e3o.<a href=\"#_edn5\" id=\"_ednref5\">[v]<\/a><\/p>\n\n\n\n<p>\u201cPara garantir que este medicamento chegue a quem precisa, usaremos a nossa for\u00e7a de visita\u00e7\u00e3o para dar suporte e levar informa\u00e7\u00e3o cient\u00edfica para mais de 40 mil m\u00e9dicos, entre cardiologistas, endocrinologistas, geriatras e cl\u00ednicos gerais em todo o Brasil. O aumento da expectativa de vida do brasileiro traz o desafio de gerir doen\u00e7as cr\u00f4nicas com mais efici\u00eancia. A nossa resposta \u00e9 oferecer inova\u00e7\u00e3o que simplifique a jornada do paciente e ampliar a nossa atua\u00e7\u00e3o na educa\u00e7\u00e3o m\u00e9dica, trazendo mais acessibilidade ao tratamento\u201d, afirma CEO da Biolab &amp; Co, Fabio Amorosino.<\/p>\n\n\n\n<p>O lan\u00e7amento do medicamento no Brasil \u00e9 fruto de uma parceria estrat\u00e9gica de co-marketing entre a Biolab e a Novartis. Esta uni\u00e3o combina a for\u00e7a de mercado e a capilaridade da Biolab com a expertise global em inova\u00e7\u00e3o da Novartis, acelerando o acesso de pacientes e m\u00e9dicos a tratamentos de \u00faltima gera\u00e7\u00e3o para a sa\u00fade do cora\u00e7\u00e3o.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><\/blockquote>\n\n\n\n<ul>\n<li><a id=\"_edn1\" href=\"#_ednref1\">[i]<\/a> Cestari VRF et al. Distribui\u00e7\u00e3o espacial da mortalidade por insufici\u00eancia card\u00edaca no Brasil, 1996\u20132017. Arquivos Brasileiros de Cardiologia. 2021;118(1):41\u201151. doi: 10.36660\/abc.20201325<\/li>\n\n\n\n<li><a href=\"#_ednref2\" id=\"_edn2\">[ii]<\/a> <a href=\"https:\/\/www.gov.br\/conitec\/pt-br\/midias\/consultas\/relatorios\/2024\/sociedade\/relatorio-para-a-sociedade-476-dave#:~:text=Estima%2Dse%20que%20a%20insufici%C3%AAncia%20card%C3%ADaca%20afete%2026,240%20mil%20casos%20novos%20a%20cada%20ano\">https:\/\/www.gov.br\/conitec\/pt-br\/midias\/consultas\/relatorios\/2024\/sociedade\/relatorio-para-a-sociedade-476-dave#:~:text=Estima%2Dse%20que%20a%20insufici%C3%AAncia%20card%C3%ADaca%20afete%2026,240%20mil%20casos%20novos%20a%20cada%20ano<\/a><\/li>\n\n\n\n<li><a href=\"#_ednref3\" id=\"_edn3\">[iii]<\/a> De Albuquerque DC, De Barros E Silva PGM, Lopes RD, Hoffmann-Filho CR, Nogueira PR, Reis H, Nishijuka FA, Martins SM, De Figueiredo Neto JA, Pavanello R, De Souza Neto JD, Danzmann LC, Gemelli JR, Rohde LEP, Hernandes ME, Rivera MAM, Sim\u00f5es MV, Dos Santos ES, Canesin MF, Zilli AC, Santos RHN, Jesuino IA, Mourilhe-Rocha R, Moura LZ, Marcondes-Braga FG, Mesquita ET; BREATHE INVESTIGATORS. In-Hospital Management and Long-term Clinical Outcomes and Adherence in Patients With Acute Decompensated Heart Failure: Primary Results of the First Brazilian Registry of Heart Failure (BREATHE). J Card Fail. 2024 May;30(5):639-650. doi: 10.1016\/j.cardfail.2023.08.014. Epub 2023 Aug 28. PMID: 37648061<\/li>\n\n\n\n<li><a href=\"#_ednref4\" id=\"_edn4\">[iv]<\/a> Lewis EF, Claggett BL, McMurray JJV, Packer M, Lefkowitz MP, Rouleau JL, Liu J, Shi VC, Zile MR, Desai AS, Solomon SD, Swedberg K. Health-Related Quality of Life Outcomes in PARADIGM-HF. Circ Heart Fail. 2017 Aug;10(8):e003430. doi: 10.1161\/CIRCHEARTFAILURE.116.003430. PMID: 28784687.<\/li>\n\n\n\n<li><a id=\"_edn5\" href=\"#_ednref5\">[v]<\/a> Pascual\u2011Figal D, Bay\u00e9s\u2011Genis&nbsp; A, Beltr\u00e1n\u2011Troncoso P, et al. Sacubitril\u2011Valsartan: Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. Frontiers in Cardiovascular Medicine. 2021;8:754499. doi: 10.3389\/fcvm.2021.754499<\/li>\n<\/ul>\n","protected":false},"featured_media":17323,"template":"","categories":[1576],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.4 (Yoast SEO v24.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca - Biolab &amp; Co<\/title>\n<meta name=\"description\" content=\"A Biolab Farmac\u00eautica, l\u00edder em medicamentos para a sa\u00fade cardiovascular, amplia a sua atua\u00e7\u00e3o em cardiologia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biolabeco.com.br\/zh\/\u5a92\u4f53\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca\" \/>\n<meta property=\"og:description\" content=\"A Biolab Farmac\u00eautica, l\u00edder em medicamentos para a sa\u00fade cardiovascular, amplia a sua atua\u00e7\u00e3o em cardiologia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biolabeco.com.br\/zh\/\u5a92\u4f53\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/\" \/>\n<meta property=\"og:site_name\" content=\"Biolab &amp; Co\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-02T14:38:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1800\" \/>\n\t<meta property=\"og:image:height\" content=\"1013\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/\",\"url\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/\",\"name\":\"Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca - Biolab &amp; Co\",\"isPartOf\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg\",\"datePublished\":\"2026-05-06T14:25:39+00:00\",\"dateModified\":\"2026-06-02T14:38:35+00:00\",\"description\":\"A Biolab Farmac\u00eautica, l\u00edder em medicamentos para a sa\u00fade cardiovascular, amplia a sua atua\u00e7\u00e3o em cardiologia.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#breadcrumb\"},\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#primaryimage\",\"url\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg\",\"contentUrl\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg\",\"width\":1800,\"height\":1013,\"caption\":\"L\u00edder em cardiologia, farmac\u00eautica passa a oferecer medicamento para condi\u00e7\u00e3o que afeta 2 milh\u00f5es de brasileiros\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biolabeco.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\",\"url\":\"https:\/\/www.biolabeco.com.br\/\",\"name\":\"Biolab\",\"description\":\"Na Biolab &amp; Co, ci\u00eancia e cuidado caminham juntos. Saiba como promovemos sa\u00fade com responsabilidade socioambiental e tecnologia.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biolabeco.com.br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-CN\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca - Biolab &amp; Co","description":"A Biolab Farmac\u00eautica, l\u00edder em medicamentos para a sa\u00fade cardiovascular, amplia a sua atua\u00e7\u00e3o em cardiologia.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biolabeco.com.br\/zh\/\u5a92\u4f53\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/","og_locale":"zh_CN","og_type":"article","og_title":"Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca","og_description":"A Biolab Farmac\u00eautica, l\u00edder em medicamentos para a sa\u00fade cardiovascular, amplia a sua atua\u00e7\u00e3o em cardiologia.","og_url":"https:\/\/www.biolabeco.com.br\/zh\/\u5a92\u4f53\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/","og_site_name":"Biolab &amp; Co","article_modified_time":"2026-06-02T14:38:35+00:00","og_image":[{"width":1800,"height":1013,"url":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/","url":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/","name":"Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca - Biolab &amp; Co","isPartOf":{"@id":"https:\/\/www.biolabeco.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#primaryimage"},"image":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg","datePublished":"2026-05-06T14:25:39+00:00","dateModified":"2026-06-02T14:38:35+00:00","description":"A Biolab Farmac\u00eautica, l\u00edder em medicamentos para a sa\u00fade cardiovascular, amplia a sua atua\u00e7\u00e3o em cardiologia.","breadcrumb":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/"]}]},{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#primaryimage","url":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg","contentUrl":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg","width":1800,"height":1013,"caption":"L\u00edder em cardiologia, farmac\u00eautica passa a oferecer medicamento para condi\u00e7\u00e3o que afeta 2 milh\u00f5es de brasileiros"},{"@type":"BreadcrumbList","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biolabeco.com.br\/"},{"@type":"ListItem","position":2,"name":"Biolab Farmac\u00eautica amplia portf\u00f3lio com terapia para insufici\u00eancia card\u00edaca"}]},{"@type":"WebSite","@id":"https:\/\/www.biolabeco.com.br\/#website","url":"https:\/\/www.biolabeco.com.br\/","name":"Biolab","description":"\u5728Biolab &amp; Co\uff0c\u79d1\u5b66\u4e0e\u5173\u6000\u76f8\u8f85\u76f8\u6210\u3002\u4e86\u89e3\u6211\u4eec\u5982\u4f55\u901a\u8fc7\u793e\u4f1a\u4e0e\u73af\u5883\u8d23\u4efb\u4ee5\u53ca\u5148\u8fdb\u6280\u672f\u6765\u4fc3\u8fdb\u5065\u5eb7\u3002.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biolabeco.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-CN"}]}},"_links":{"self":[{"href":"https:\/\/www.biolabeco.com.br\/zh\/wp-json\/wp\/v2\/imprensa\/17322"}],"collection":[{"href":"https:\/\/www.biolabeco.com.br\/zh\/wp-json\/wp\/v2\/imprensa"}],"about":[{"href":"https:\/\/www.biolabeco.com.br\/zh\/wp-json\/wp\/v2\/types\/imprensa"}],"version-history":[{"count":4,"href":"https:\/\/www.biolabeco.com.br\/zh\/wp-json\/wp\/v2\/imprensa\/17322\/revisions"}],"predecessor-version":[{"id":17329,"href":"https:\/\/www.biolabeco.com.br\/zh\/wp-json\/wp\/v2\/imprensa\/17322\/revisions\/17329"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/zh\/wp-json\/wp\/v2\/media\/17323"}],"wp:attachment":[{"href":"https:\/\/www.biolabeco.com.br\/zh\/wp-json\/wp\/v2\/media?parent=17322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/zh\/wp-json\/wp\/v2\/categories?post=17322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}